Ex vivo-expanded human CD19+CD73-CD25+CD71+TIM-1+ B regulatory cells can prolong allograft survival in a humanized mouse model of skin transplantation and are dependent on TIM1-mediated regulation of STAT3 signaling

Ex vivo-expanded human CD19+CD73-CD25+CD71+TIM-1+ B regulatory cells can prolong allograft survival in a humanized mouse model of skin transplantation and are dependent on TIM1-mediated regulation of STAT3 signaling

Detalles Bibliográficos
Autores principales:	Shankar, S, Stolp, J, Juvet, S, Hester, J, Wood, K
Formato:	Conference item
Publicado:	Wiley 2018

Ejemplares similares

Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
por: Shankar, S, et al.
Publicado: (2022)

Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
por: S. Shankar, et al.
Publicado: (2022-06-01)

PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis.
por: Ming-Ke Qiu, et al.
Publicado: (2015-01-01)

CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival
por: Huazhen Liu, et al.
Publicado: (2019-02-01)

The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
por: Liyun Lin, et al.
Publicado: (2025-02-01)

Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions
por: Tanja D de Gruijl, et al.
Publicado: (2023-12-01)

Histopathological Evaluation of LAG-3, TIM-3 AND CD38 Levels in Meningiomas
por: Uzay Erdoğan, et al.
Publicado: (2021-12-01)

Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function
por: Franziska Blaeschke, et al.
Publicado: (2022-04-01)

High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
por: Elisabet Aliagas, et al.
Publicado: (2014-01-01)

Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma
por: Tingting Zhang, et al.
Publicado: (2020-01-01)

Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73
por: Jarvis, LB, et al.
Publicado: (2021)

Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73
por: Lorna B. Jarvis, et al.
Publicado: (2021-10-01)

CD56 and Tim-3 molecule expression in different monocyte subsets in physiological pregnancy
por: E. G. Orlova, et al.
Publicado: (2023-06-01)

Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection.
por: Ali Sakhdari, et al.
Publicado: (2012-01-01)

Tim-3 on CD4 T cells is associated with pathology in experimental autoimmune encephalomyelitis of mouse
por: Qi Guo
Publicado: (2021-07-01)

QUANTITATIVE EXPRESSION FEATURES OF PD-1 AND TIM-3 CHECKPOINT MOLECULE RECEPTORS ON CD4⁺ AND CD8⁺ T-CELLS IN BREAST CANCER OF VARYING PROGRESSION DEGREES
por: Yu. A. Shevchenko, et al.
Publicado: (2021-10-01)

Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions.
por: Yueqin Qiu, et al.
Publicado: (2012-01-01)

Corrigendum to “Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma”
por: Tingting Zhang, et al.
Publicado: (2021-01-01)

Prospective isolation of human fibroadipogenic progenitors with CD73
por: Natalya A. Goloviznina, et al.
Publicado: (2020-07-01)

CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog.
por: Watson, C, et al.
Publicado: (1993)

Monoclonal antibody targeting of CD4(+) and CD8(+) cells for prolongation of baboon renal allograft survival.
por: Hazinedaroglu, S, et al.
Publicado: (2005)

The Role of TIM-1 and CD300a in Zika Virus Infection Investigated with Cell-Based Electrical Impedance
por: Merel Oeyen, et al.
Publicado: (2024-07-01)

Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer
por: Pauline Weimer, et al.
Publicado: (2022-03-01)

Elevated Expression of Tim-3 and PD-1 Immune Checkpoint Receptors on T-CD4+ Lymphocytes of Patients with Asthma
por: Ali Mosayebian, et al.
Publicado: (2018-12-01)

Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
por: Alberto L. Horenstein, et al.
Publicado: (2018-04-01)

Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy
por: Shirin Lak, et al.
Publicado: (2022-12-01)

TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.
por: Brian Tomkowicz, et al.
Publicado: (2015-01-01)

Tim4 deficiency reduces CD301b+ macrophage and aggravates periodontitis bone loss
por: Ziming Wang, et al.
Publicado: (2024-02-01)

TIM‐3 as a potential exhaustion marker in CD4+ T cells of COVID‐19 patients
por: Zahra Modabber, et al.
Publicado: (2021-12-01)

CD28 engagement inhibits CD73-mediated regulatory activity of CD8+ T cells
por: Yo-Ping Lai, et al.
Publicado: (2021-05-01)

Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells
por: Eleonora Tresoldi, et al.
Publicado: (2011-09-01)

Strict tropism for CD71+/ CD234+ human reticulocytes limits Plasmodium cynomolgi's zoonotic potential
por: Kosaisavee, V, et al.
Publicado: (2017)

Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells
por: Elena Tassi, et al.
Publicado: (2023-10-01)

Rapamycin relieves lupus nephritis by regulating TIM-3 and CD4+CD25+Foxp3+ Treg cells in an MRL/lpr mouse model
por: Yan-fang Gao, et al.
Publicado: (2022-09-01)

Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy.
por: Bhawna Poonia, et al.
Publicado: (2014-01-01)

Activation-Induced TIM-4 Expression Identifies Differential Responsiveness of Intestinal CD103+ CD11b+ Dendritic Cells to a Mucosal Adjuvant.
por: Kerry L Hilligan, et al.
Publicado: (2016-01-01)

Suppression of allograft rejection by Tim-1-Fc through cross-linking with a novel Tim-1 binding partner on T cells.
por: Liang Xiao, et al.
Publicado: (2011-01-01)

Effect of Interferon- on Expression of CD39 and CD73 Genes in the Human Wharton’s Jelly Mesenchymal Stem Cells
por: Maryam Rahimzadeh, et al.
Publicado: (2018-04-01)

1023 Cell-intrinsic Tim-3 is required for optimal CD8 response to acute LCMV infection
por: Lawrence Kane, et al.
Publicado: (2023-11-01)

Immune function assessing of TIM3/CD28‐modified CD19 CAR‐T cells and general CD19 CAR‐T cells through a high‐throughput single‐cell microarray platform
por: Chao Wang, et al.
Publicado: (2024-01-01)